These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29789899)

  • 21. MULTIPLE BILATERAL RETINAL BREAKS AS A LONG-TERM COMPLICATION OF RETINOPATHY OF PREMATURITY TREATED WITH INTRAVITREAL BEVACIZUMAB.
    Teixeira-Pinto T; Paccola ML; Scott IU; Jorge R
    Retin Cases Brief Rep; 2022 Sep; 16(5):572-575. PubMed ID: 32694276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treated cases of retinopathy of prematurity in Germany : 5-year data from the Retina.net ROP registry].
    Walz JM; Bemme S; Reichl S; Akman S; Breuß H; Süsskind D; Glitz B; Müller VC; Wagenfeld L; Gabel-Pfisterer A; Aisenbrey S; Engelmann K; Koutsonas A; Krohne TU; Stahl A;
    Ophthalmologe; 2018 Jun; 115(6):476-488. PubMed ID: 29637302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and future trends in treatment of severe retinopathy of prematurity.
    Wallace DK; Wu KY
    Clin Perinatol; 2013 Jun; 40(2):297-310. PubMed ID: 23719311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Off-label use of intravitreal bevacizumab for severe retinopathy of prematurity].
    Alba LE; Zaldua RA; Masini RA
    Arch Soc Esp Oftalmol; 2015 Feb; 90(2):81-6. PubMed ID: 25459682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-vascular endothelial growth factor (VEGF) drugs compared to laser photocoagulation for treatment of type 1 retinopathy of prematurity.
    González C R; Díaz C M; Garretón C R
    Medwave; 2022 Jan; 22(1):e8507. PubMed ID: 35100244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP).
    Li Z; Zhang Y; Liao Y; Zeng R; Zeng P; Lan Y
    BMC Ophthalmol; 2018 Jan; 18(1):19. PubMed ID: 29378530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low dose versus conventional dose of intravitreal bevacizumab injection for retinopathy of prematurity: a case series with paired-eye comparison.
    Han J; Kim SE; Lee SC; Lee CS
    Acta Ophthalmol; 2018 Jun; 96(4):e475-e478. PubMed ID: 27011262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.
    Hwang CK; Hubbard GB; Hutchinson AK; Lambert SR
    Ophthalmology; 2015 May; 122(5):1008-15. PubMed ID: 25687024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity.
    Erol MK; Coban DT; Sari ES; Bilgin AB; Dogan B; Ozdemir O; Tunay ZO
    Arq Bras Oftalmol; 2015; 78(6):340-3. PubMed ID: 26677033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity.
    Wu WC; Lien R; Liao PJ; Wang NK; Chen YP; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC
    JAMA Ophthalmol; 2015 Apr; 133(4):391-7. PubMed ID: 25569026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New insights in diagnosis and treatment for Retinopathy of Prematurity.
    Cernichiaro-Espinosa LA; Olguin-Manriquez FJ; Henaine-Berra A; Garcia-Aguirre G; Quiroz-Mercado H; Martinez-Castellanos MA
    Int Ophthalmol; 2016 Oct; 36(5):751-60. PubMed ID: 26767656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF).
    Tsai AS; Chou HD; Ling XC; Al-Khaled T; Valikodath N; Cole E; Yap VL; Chiang MF; Chan RVP; Wu WC
    Prog Retin Eye Res; 2022 May; 88():101018. PubMed ID: 34763060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.
    Cayabyab R; Ramanathan R
    Neonatology; 2016; 109(4):369-76. PubMed ID: 27251645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial.
    Stahl A; Krohne TU; Eter N; Oberacher-Velten I; Guthoff R; Meltendorf S; Ehrt O; Aisenbrey S; Roider J; Gerding H; Jandeck C; Smith LEH; Walz JM;
    JAMA Pediatr; 2018 Mar; 172(3):278-286. PubMed ID: 29309486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental Evidence Behind Clinical Trial Outcomes in Retinopathy of Prematurity.
    Hartnett ME; Toth CA
    Ophthalmic Surg Lasers Imaging Retina; 2019 Apr; 50(4):228-234. PubMed ID: 30998244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal bevacizumab monotherapy for retinopathy of prematurity.
    Şahin A; Şahin M; Cingü AK; Çınar Y; Türkcü FM; Yüksel H; Kaya S; Arı Ş; Caça İ
    Pediatr Int; 2013 Oct; 55(5):599-603. PubMed ID: 23659781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buckling surgery and supplemental intravitreal bevacizumab or photocoagulation on stage 4 retinopathy of prematurity eyes.
    Futamura Y; Asami T; Nonobe N; Kachi S; Ito Y; Sato Y; Hayakawa M; Terasaki H
    Jpn J Ophthalmol; 2015 Nov; 59(6):378-88. PubMed ID: 26265249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evidence-based meta-analysis of vascular endothelial growth factor inhibition in pediatric retinal diseases: part 1. Retinopathy of prematurity.
    Mititelu M; Chaudhary KM; Lieberman RM
    J Pediatr Ophthalmol Strabismus; 2012; 49(6):332-40. PubMed ID: 22938516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current Practice Patterns for Treatment of Retinopathy of Prematurity.
    Tawse KL; Jeng-Miller KW; Baumal CR
    Ophthalmic Surg Lasers Imaging Retina; 2016 May; 47(5):491-5. PubMed ID: 27183557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: comparison between Ranibizumab and Bevacizumab.
    Chen SN; Lian I; Hwang YC; Chen YH; Chang YC; Lee KH; Chuang CC; Wu WC
    Retina; 2015 Apr; 35(4):667-74. PubMed ID: 25462435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.